About Roche

Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.

About Roche in India

Partnering India in its healthcare journey

We at Roche India, are guided by our bold vision statement: “We inspire people to transform healthcare in India and care for every patient’s life through sustainable, innovative solutions”. Our strong network of over 100 distributors, and a workforce of over 250 committed employees strive tirelessly each day to realize this vision.

For more than 60 years, Roche has been committed to making a difference to the lives of people in India. From being a key distribution market for the iconic cough syrup Sirolin, to manufacturing vitamins in the late 1950s to the recent advanced immunotherapy medicines for treating different forms of cancer, we have endeavored to bring the most innovative and path-breaking drugs to Indian patients. Today, we have a cutting-edge exclusive product portfolio of power brands across our focus therapy areas of:

Apart from our core portfolio in the above therapy areas, we also have a robust product portfolio of non exclusive brands, marketed and distributed through our partnerships with Cipla and Entero.

A vision to transform India’s healthscape

We are cognizant of the fact that the Indian healthscape is a varied and complex one, with several structural issues. In order to make our innovative therapies truly accessible, Roche Pharma India adopted a pioneering business operating model, the first-of-its kind to be implemented in the Indian pharma industry. Our unique decentralized cluster based operating model, allows us the agility to respond to customer needs in a faster and more efficient manner; while serving our patients seamlessly. With a strong foundation set in place, Roche Pharma India is poised to deliver greater impact in the years to come. With an impressive pipeline of 20+ new product launches and indication extensions planned in the next 3-5 years in the areas of Oncology, Hematology, Ophthalmology, Neurology and Infectious  Diseases, we truly are dedicated to transforming patient lives.

Supporting patients every step of the way with The Blue Tree Program

Grappling with any disease can take a major toll, be it physically, emotionally or financially; not just for the patient but even for their caregivers. At Roche Pharma India, our flagship patient support program - The Blue Tree - aims to extend support and care at every step of a patient’s journey. The Blue Tree Program provides cancer, hemophilia and rare disease patients, and their families with disease awareness and testing, funding solutions, home delivery of medicines, free drug support, treatment adherence support, reimbursement support and standardized reports. The Blue Tree Program aims to truly simplify the patient’s journey.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us atOR please call the Roche India Safety Unit onor E-mail us at

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout RochePersonalised HealthcareSolutionsRoche careersMediaPrivacy policyLegal statement